We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Mr David Crundwell joined the Commission on Human Medicines on 12 June 2023 as a lay representative.
The Medicines and Healthcare products Regulatory Agency (MHRA) has launched new guidance to highlight the latest safety advice on the steps to take during anaphylaxis.…
The government commissions the Advisory Council on the Misuse of Drugs (ACMD) to review the harms of Xylazine and 2-Methyl-AP-237.
First published during the 2022 to 2024 Sunak Conservative government
New measures to commence 1 January 2025.
Kieron Banks (34) was sentenced today at the Nightingale Court in Wolverhampton for the illegal possession and intent to supply prescription-only medication valued at over £2m following investigations by the Medicines and Healthcare products Regulatory Agency (MHRA).…
The new COVID-19 vaccine from SK Chemicals, has been authorised after meeting the MHRA’s required safety, quality and effectiveness standards.
The MHRA has today launched a public consultation on the revised ICH guideline on Good Clinical Practice.
A £650 million war-chest to fire up the UK’s life sciences sector and drive forward the government’s priority to grow the economy has been unveiled by the Chancellor of the Exchequer Jeremy Hunt today 25 May 2023.
The new recognition routes open additional options for the MHRA to bring cutting-edge medicines faster to UK patients by leveraging the expertise and decision-making of trusted regulatory partners
The Innovative Devices Access Pathway (IDAP), set for launch later in 2023, will be operated by the Medicines and Healthcare products Regulatory Agency (MHRA), the National Institute for Health and Care Excellence (NICE), Health Technology Wales (HTW) and Scottish Health Technology Group…
A brand-new challenge for artificial intelligence and machine learning developers, to build models that can predict heart failure-related health outcomes for veterans has been launched by a collaboration between regulators a…
The Medicines and Healthcare products Regulatory Agency (MHRA) has today announced it will be the first drug safety regulator in the world to pilot its own genetic ‘biobank’, launching 1 June 2023…
Following a public consultation and the review of a reclassification application from the manufacturer, the MHRA has decided that Aquiette 2.5mg Tablets will remain a prescription-only medicine.
Patients, or carers of patients, who carry Emerade 300 or 500 microgram adrenaline auto-injector pens should contact their GP and obtain a prescription for, and be supplied with an alternative brand. They should then return …
The Department of Health and Social Care has today announced the reappointment of two Non-Executive Directors of the MHRA from 1 September.
Health and Social Care Secretary Steve Barclay delivered a speech to the Association of the British Pharmaceutical Industry (ABPI) annual conference.
Findings from research by the MHRA have been published, evaluating two different approaches to cancer therapies which harness the immune system to determine which better targets cancer cells and would reduce side effects for…
Neil O'Brien delivered a speech at Policy Exchange on government plans to cut smoking rates and tackle underage vaping.
Committee recommends COVID-19 vaccine for children with underlying medical conditions.
Four life sciences companies from across the UK will benefit from the first tranche of Life Sciences Innovative Manufacturing Fund (LSIMF) grants.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).